Document is current
Any future updates will be listed below
-
Authors
Li, Xue-Ping https://orcid.org/0000-0002-4588-065X
Gao, Yan
Zhao, Bai-Tian
Dai, Yu-Ting
Mao, Jia-Ying
Liang, Yang
Jiang, Lu
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82300184, 82270170)
Fundamental Research Funds for the Central Universities (24qnpy291)
Shanghai Rising-Star Program (22QA1405600)
- License Information
-
More Information
Article History
Received: 31 March 2025
Accepted: 27 May 2025
First Online: 24 July 2025
Declarations
:
: The bone marrow samples of primary t(8;21) AML were collected complied with the Declaration of Helsinki. Detailed clinical information of the samples and treatment regimens was described in Table . All patients provided written informed, and this study was approved by the Ethics Committee of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (2023-355) and Sun Yat-sen University Cancer Center (G2023-084-01,G2023-180-01).
: All authors participated in the writing of the manuscript and agreed to the final version of the manuscript.
: All the authors declare there was no conflict of interest.
